1Johansen K.Eficacy of metfomin in the treayment of NIDDM.Diabetes care 1999,22:33-36.
2Abbasi F,Kamath V,Rizvi AA,et al.Resuits of a placecontroled study of the metbolic effects of the addiyion of metformin to sulfonylurea-treated patients:evidence for a cental role of adipose tissue.Diabetes Care 1997,20:1863-1869.
3Robinson A,Burke J.Robinson S,et al.The effects of erformin on glyceic control and serumlipids in insulin-treated NIDDM patients with suboplimal metabolica control.Diabetes Care 1998,21:701-704.
4Hirschberg Y,Pietri A,Karara AH,et al.lproved control of mealtime glucose excursions with coadministration of nateglinide and metformin .Diaberes Care 2000,23:349-352.
5Mannuce E.Ognibene A,Creasco F.Effect of metformin on glucagon-like peptide1(GLP-1)and leptin levels in obese nondiabetes subjects.Diabetes care 2001,24:489-352.
6Rosenstock J,Brown A,Fischer J,et al.Efficacy and safety of acarbose in metforin-treated patients with type 2 diabetes.Diabetes Care 1998,21:2050-2054.
7Lacigova S,Rusavy Z,Jankovee ZZ,et al.efformin i the treatment of type 2 diabetes-a placebo controlled study.Caslek Cesk 2001,140:302-61.
1Anfosso F,Chomiki N,Alessi MC,et al.Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line HEP G2: Metformin inhibits the stimulating effect of insulin[].The Journal of Clinical Investigation.1993
2Dunaif A,Graf M,Mandeli J,et al.Characterization of groups of hyperinsulinemia[].The Journal of Clinical Endocrinology.1987
3Gilkison C,Stuart CA.Assessement of patients with acanthosis nigricans skin lesion for hyperinsulinia, insulin resistance and diabetes[].Nurse Practitioner.1992
4Scheen AJ,Letiexhe MR,Lefebvre PJ.Short administration of metformin improves insulin sensitivity and android obese subjects with impaired glucose tolerance[].Diabetic Medicine.1995
5Landin K,Tengbom L,Smith U.Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors[].Journal of Internal Medicine.1991
6Cederholm J,Wibell K.Insulin release and peripheral sensitivity at the oral glucose tolerance test[].Diabetes Research and Clinical Practice.1990
7Taniguchi A,Nakai Y,Fukushima H,et al.Pathogenic factor responsible for glucose tolerance in patients with NIDDM[].Diabetes.1992
8Diamanti-Kandarakise E,Kouli C,Tsianateli T,et al.Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome[].European Journal of Endocrinology.1988
